India-based Bio-gen Extracts is allocating $10 million to enhance its production plant in Bangalore. The upgrade aims to support the manufacturing of new healthspan-related ingredients and improve the delivery of bioactive compounds and formulations.
The investment will enable the company to expand its product offerings and increase production efficiency. This move reflects Bio-gen Extracts’ focus on innovation in the health and wellness sector.
**Why this matters**
The investment highlights growing interest in healthspan, which focuses on extending healthy living years. Upgrading manufacturing capabilities can accelerate the development and availability of advanced bioactive ingredients, potentially benefiting consumers and the broader nutraceutical industry.
Source: NewsData